Abortion providers were suddenly faced with a conundrum over the weekend, after the 5th Circuit Court of Appeals reinstated a requirement that the abortion pill mifepristone be dispensed in person only: If patients can no longer get it by telehealth and mail, what are their options?
Subscribe to read this story ad-free
Get unlimited access to ad-free articles and exclusive content.
